Search Results 901-910 of 19307 for Hemoglobin

  1. Myelofibrosis - Symptoms and causes - Mayo Clinic

    Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.

  2. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  4. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

    Hemoglobin A1c (HbA1c) ≥ 6.5% present; or; Any (2) PDMs present on consecutive or simultaneous testing: Fasting Blood Glucose (FBG) ≥ 126 mg/dl;; Hemoglobin ...

  5. HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis - Mayo Clinic

    corrected for hemoglobin > 50% and forced expiratory volume in first second (FEV1) predicted > 50% based on most recent pulmonary function test (PFT) ...

  6. A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma - Mayo Clinic

    Hemoglobin ≥ 8 g/dL (≥ 80 g/L; may be transfused):. Hemoglobin: __________Date Obtained: ______. Creatinine ≤ 2.0 x ULN: Creatinine: ______ ...

  7. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma - Mayo Clinic

    Hemoglobin ≥ 9 g/dL without transfusion within 2 weeks of the first study drug administration;; Part 2; Absolute neutrophil count ≥ 1500/μL (≥ 1.5 × 10^9 ...

  8. Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer - Mayo Clinic

    ECOG Performance Status (PS) 0, 1, or 2. The following laboratory values obtained ≤ 30 days prior to pre-registration: Hemoglobin ≥ 10.0 g/dL;; Absolute ...

  9. Low white blood cell count - Mayo Clinic

    White blood cells are made in bone marrow — the spongy tissue inside some of the larger bones. Conditions that affect the bone marrow are the usual causes ...

  10. Hematology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...